Menu
Search
|

Menu

Close
X

Edwards Lifesciences Corp EW.N (New York Stock Exchange)

135.64 USD
+1.97 (+1.47%)
As of 4:01 PM EST
chart
Previous Close 133.67
Open 134.11
Volume 206,538
3m Avg Volume 368,614
Today’s High 135.68
Today’s Low 133.05
52 Week High 138.40
52 Week Low 89.25
Shares Outstanding (mil) 211.62
Market Capitalization (mil) 28,287.23
Forward P/E 49.51
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.95 Mean rating from 22 analysts

KEY STATS

Revenue (mm, USD)
FY17
3,435
FY16
2,964
FY15
2,494
EPS (USD)
FY17
2.700
FY16
2.614
FY15
2.250
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
49.51
34.59
Price to Sales (TTM)
vs sector
8.23
8.08
Price to Book (MRQ)
vs sector
9.48
5.24
Price to Cash Flow (TTM)
vs sector
42.51
25.98
Total Debt to Equity (MRQ)
vs sector
35.06
15.60
LT Debt to Equity (MRQ)
vs sector
14.83
12.18
Return on Investment (TTM)
vs sector
14.11
13.67
Return on Equity (TTM)
vs sector
20.94
15.40

EXECUTIVE LEADERSHIP

Michael Mussallem
Chairman of the Board, Chief Executive Officer, Since 2000
Salary: $976,731.00
Bonus: --
Scott Ullem
Chief Financial Officer, Corporate Vice President, Since 2014
Salary: $555,309.00
Bonus: --
Donald Bobo
Corporate Vice President - Heart Valve Therapy, Since 2007
Salary: $557,668.00
Bonus: --
Catherine Szyman
Corporate Vice President- Critical Care, Since 2015
Salary: $513,461.00
Bonus: --
Patrick Verguet
Corporate Vice President- Europe, Middle East and Africa, Since 2004
Salary: $604,818.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

1 Edwards Way
IRVINE   CA   92614-5688

Phone: +1949.2502500

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.

SPONSORED STORIES